Adult ID

HIV/TB/STD

Global ID

Oral Abstract

229 - The End of AIDS Starts with Prevention

Presentations:

• 10:30 AM - 10:45 AM

  1961 - Grindr™ on Screen Activity on iPhones Correlates with HIV Risk and Substance Use in Men Who Have Sex with Men, San Diego
  Martin Hoenigl, MD – University of California, San Diego; Susan J. Little, MD – University of California, San Diego; Jamila K. Stockman, PhD – University of California, San Diego; Britt Skaathun, PhD – University of California, San Diego; David Grelotti, MD – University of California, San Diego; Nadir Weibel, PhD – University of California, San Diego; Davey M. Smith, MD – University of California, San Diego
• 10:45 AM - 11:00 AM

  1962 - Renal Outcomes for Participants Taking F/TAF versus F/TDF for HIV PrEP in the DISCOVER Trial
  Anthony Mills, MD – Men’s Health Foundation; Kimberly Workowski, MD – Emory University; Thomas Campbell, MD – University of Colorado; Paul Benson, DO – Be Well Medical Center; Gordon Crofoot, MD – Crofoot Research Center; Laura Salazar, MD – St Joseph Heritage Healthcare; Onyema Ogbuagu, MD – Yale University; Peter Shalit, MD, PhD; Benoit Trottier, MD – Clinique de Médecine Urbaine du Quartier Latin; Christoph C. Carter, MD – Gilead Sciences Inc.; Pamela Wong, MPH – Gilead Sciences Inc.; Diana M. Brainard, MD – Gilead Sciences Inc.; Scott McCallister, MD – Gilead Sciences Inc.; Moupali Das, MD – Gilead Sciences Inc.; Susanne Doblecki-Lewis, MD, MSPH – University of Miami
• 11:00 AM - 11:15 AM

  1963 - PrEP Significantly Reduces the Rate of New HIV Diagnoses in US Metropolitan Statistical Areas independent of Treatment as Prevention (2012-2017)
  Robertino M. Mera-Giler, MD, PhD – PVE; Moupali Das, MD – Gilead Sciences Inc.; Trevor Hawkins, MD – Gilead Sciences Inc.; David Magnuson, PharmD – Gilead Sciences Inc.; Julius Asubonteng, PhD – Gilead Sciences Inc.; Scott McCallister, MD – Gilead Sciences Inc.
• 11:15 AM - 11:30 AM

  1965 - PrEP On the Go! Implementation Mobile PrEP, STI, and HIV Prevention Services in South Florida
  Susanne Doblecki-Lewis, MD, MSPH – University of Miami; Erin Kobetz, PhD – University of Miami; John Byrne – Prevention 305; Stefani Butts, BA – University of Miami; Marco Torrealba, BA – Prevention 305; Katie Klose, MSW – University of Miami; Angela McGaugh, MD/MPH – University of Miami; Connor Shatz – University of Miami; Carolina Scaramutti, LMHC MPH – University of Miami; Brian Baez Leon, AA – University of Miami; Gilianne Narcisse, PharmD – University of Miami; Jessica Morel, FNP-BC – University of Miami; Patrick Whiteside – PREVENTION 305; Gabriel Cardenas, PhD – University of Miami; Daniel Feaster, PhD – University of Miami; Mario Stevenson, PhD – University of Miami
• 11:30 AM - 11:45 AM

  1964 - Factors associated with HIV Seroconversion Among women attending an Urban Health Clinic in the South: A Matched Case Control Study in Atlanta, GA.
  Pauline Harrington, MPH – Emory University; Udodirim Onwubiko, MBBS, MPH – Fulton County Board of Health; Mingli Qi, PhD, MPH – Emory University; David Holland, MD – Fulton County Board of Health; Pascale Wortley, MD, MPH – Georgia Department of Public Health; Allison Chamberlain, PhD – Fulton County Board of Health

Co-Author(s)

• PH

  Pauline Harrington, MPH

  Epidemiologist
  Emory University
  Atlanta, GA

  Disclosure: Nothing to disclose
• MD

  Moupali Das, MD

  MD
  Gilead Sciences Inc.
  Foster City, CA

  Disclosure: Gilead Sciences: Employee
• EK

  Erin Kobetz, PhD

  Associate Director
  University of Miami
  Miami, FL

  Disclosure: Nothing to disclose
• SL

  Susan Little, MD

  Prof.
  University of California, San Diego
  San Diego, California

  Disclosure: Nothing to disclose
• KW

  Kimberly Workowski, MD

  Professor
  Emory University
  Atlanta, Georgia

  Disclosure: Nothing to disclose
• JB

  John Byrne

  Executive Director
  Prevention 305
  Miami, FL

  Disclosure: Nothing to disclose
• TC

  Thomas Campbell, MD

  Professor of Medicine
  University of Colorado
  Denver, CO

  Disclosure: Nothing to disclose
• TH

  Trevor Hawkins, MD

  MD
  Gilead Sciences Inc.
  Foster City, CA

  Disclosure: Gilead Sciences: Employee
• MQ

  Mingli Qi, PhD, MPH

  PhD
  Emory University
  Atlanta, GA

  Disclosure: Nothing to disclose
• JS

  Jamila Stockman, PhD

  Prof.
  University of California, San Diego
  San Diego, CA

  Disclosure: Nothing to disclose
• PB

  Paul Benson, DO

  HIV Specialist
  Be Well Medical Center
  Berkley, MI

  Disclosure: Nothing to disclose
• SB

  Stefani Butts, BA

  Clinical Research Coordinator
  University of Miami
  Miami, FL

  Disclosure: Nothing to disclose
• DH

  David Holland, MD

  Associate Professor
  Fulton County Board of Health
  Atlanta, GA

  Disclosure: Nothing to disclose
• DM

  David Magnuson, PharmD

  Senior Director
  Gilead Sciences Inc.
  Foster City, CA

  Disclosure: Gilead Sciences: Employee
• BS

  Britt Skaathun, PhD

  Postdoc
  University of California, San Diego
  San Diego, CA

  Disclosure: Nothing to disclose
• JA

  Julius Asubonteng, PhD

  Associate Director
  Gilead Sciences Inc.
  Foster City, CA

  Disclosure: Gilead Sciences: Employee
• GC

  Gordon Crofoot, MD

  Owner
  Crofoot Research Center
  Houston, TX

  Disclosure: Gilead: Grant/Research Support
  Janssen: Grant/Research Support
  Merck: Grant/Research Support
  ViiV: Grant/Research Support
• DG

  David Grelotti, MD

  Ass. Prof.
  University of California, San Diego
  San Diego, CA

  Disclosure: Nothing to disclose
• MT

  Marco Torrealba, BA

  Program Director
  Prevention 305
  Miami, FL

  Disclosure: Nothing to disclose
• PW

  Pascale Wortley, MD, MPH

  HIV Epidemiology Section Director
  Georgia Department of Public Health
  Atlanta, GA

  Disclosure: Nothing to disclose
• AC

  Allison Chamberlain, PhD

  Assistant Professor
  Fulton County Board of Health
  Atlanta, GA

  Disclosure: Nothing to disclose
• KK

  Katie Klose, MSW

  Project Manager
  University of Miami
  Miami, FL

  Disclosure: Nothing to disclose
• SM

  Scott McCallister, MD

  Executive Director
  Gilead Sciences Inc.
  Foster City, CA

  Disclosure: Gilead Sciences: Employee
• LS

  Laura Salazar, MD

  HIV Specialist
  St Joseph Heritage Healthcare
  Newport Beach, CA

  Disclosure: Gilead sciences: Scientific Research Study Investigator, Advisor or Review Panel member, Speaker's Bureau
  ViiV: Scientific Research Study Investigator, Advisor or Review Panel member, Speaker's Bureau
• NW

  Nadir Weibel, PhD

  Assoc.Prof.
  University of California, San Diego
  San Diego, CA

  Disclosure: Nothing to disclose
• AM

  Angela McGaugh, MD/MPH

  Medical Student
  University of Miami
  Miami, FL

  Disclosure: Nothing to disclose
• OO

  Onyema Ogbuagu, MD

  Associate Professor
  Yale University
  New Haven, CT

  Disclosure: Nothing to disclose
• DS

  Davey Smith, MD

  Prof.
  University of California, San Diego
  San Diego, CA

  Disclosure: Nothing to disclose
• PS

  Peter Shalit, MD, PhD

  HIV Specialist
  Seattle, WA

  Disclosure: Gilead Sciences: Advisor or Review Panel member, Research Grant or Support
  Janssen: Advisor or Review Panel member, Research Grant or Support
  Merck: Grant/Research Support, Advisor or Review Panel member
  ViiV Healthcare: Advisor or Review Panel member, Research Grant or Support
• CS

  Connor Shatz

  Student Volunteer
  University of Miami
  Miami, FL

  Disclosure: Nothing to disclose
• CS

  Carolina Scaramutti, LMHC MPH

  Research Associate
  University of Miami
  Miami, FL

  Disclosure: Nothing to disclose
• BT

  Benoit Trottier, MD

  HIV Specialist
  Clinique de Médecine Urbaine du Quartier Latin
  Montreal, QC, Canada

  Disclosure: Gilead sciences: Consultant
  Merck: Consultant
  ViiV: Consultant, Speaker's Bureau
• BB

  Brian Baez Leon, AA

  Outreach coordinator
  University of Miami
  Miami, FL

  Disclosure: Nothing to disclose
• CC

  Christoph Carter, MD

  Director, Clinical Research (MD)
  Gilead Sciences Inc.
  Foster City, CA

  Disclosure: Gilead Sciences: Employee
• GN

  Gilianne Narcisse, PharmD

  Clinical Pharmacist
  University of Miami
  Miami, FL

  Disclosure: Nothing to disclose
• PW

  Pamela Wong, MPH

  Associate Director of Biostatistics
  Gilead Sciences Inc.
  Foster City, CA

  Disclosure: Gilead Sciences: Employee
• DB

  Diana Brainard, MD

  SVP, HIV and Emerging Viral Infections
  Gilead Sciences Inc.
  Foster City, California

  Disclosure: Gilead: Employee, Shareholder
• JM

  Jessica Morel, FNP-BC

  Advanced Practice Registered Nurse
  University of Miami
  Miramar, FL

  Disclosure: Nothing to disclose
• SM

  Scott McCallister, MD

  Executive Director
  Gilead Sciences Inc.
  Foster City, CA

  Disclosure: Gilead Sciences: Employee
• PW

  Patrick Whiteside

  Project Director
  PREVENTION 305
  Miami, FL

  Disclosure: Nothing to disclose
• GC

  Gabriel Cardenas, PhD

  Lead Research Analyst
  University of Miami
  Miami, FL

  Disclosure: Nothing to disclose
• MD

  Moupali Das, MD

  MD
  Gilead Sciences Inc.
  Foster City, CA

  Disclosure: Gilead Sciences: Employee
• 

  Susanne Doblecki-Lewis, MD, MSPH

  Associate Professor of Clinical Medicine
  University of Miami
  Miami, FL

  Disclosure: Gilead Sciences: Advisory Board, Grant/Research Support
  Roche Diagnostics: Advisory Board
• DF

  Daniel Feaster, PhD

  Professor
  University of Miami
  Miami, FL

  Disclosure: Nothing to disclose
• MS

  Mario Stevenson, PhD

  Chief
  University of Miami
  Miami, FL

  Disclosure: Nothing to disclose

Moderator(s)

• 

  Michelle Cespedes, MD, MS

  Associate Professor of Medicine
  Icahn School of Medicine at Mount Sinai; Mount Sinai Health System
  New York, NY

  Disclosure: Gilead Sciences: Advisory Board
  ViiV HealthCare Inc: Advisory Board
• WH

  W. David Hardy, MD, AAHIVS

  Adjunct Professor of Medicine
  Division of Infectious Diseases, Johns Hopkins University School of Medicine
  Washington, DC

  Disclosure: CSL Behring (Calimmune): Consultant
  Enochian Biosciences: Consultant
  Gilead Sciences, Inc.: Advisory Board, Research Grant
  Janssen Pharm: Research Grant
  Merck: Advisory Board, Research Grant
  ViiV HealthCare Inc: Advisory Board, Consultant, Research Grant

Presenting Author(s)

• 

  Susanne Doblecki-Lewis, MD, MSPH

  Associate Professor of Clinical Medicine
  University of Miami
  Miami, FL

  Disclosure: Gilead Sciences: Advisory Board, Grant/Research Support
  Roche Diagnostics: Advisory Board
• MH

  Martin Hoenigl, MD

  Ass Prof
  University of California, San Diego
  San Diego, CA

  Disclosure: Gilead: Grant/Research Support
• RM

  Robertino Mera-Giler, MD, PhD

  Executive Director
  PVE
  Foster City, CA

  Disclosure: Gilead Sciences: Employee, Shareholder
• AM

  Anthony Mills, MD

  Chief Medical Officer
  Men’s Health Foundation
  Los Angeles, California

  Disclosure: Bristol Myers Squibb: Grant/Research Support
  Gilead Sciences: Consultant, Grant/Research Support
  Merck: Consultant, Grant/Research Support
  ViiV Healthcare: Consultant, Grant/Research Support
• UO

  Udodirim Onwubiko, MBBS, MPH

  Epidemiologist
  Fulton County Board of Health
  Atlanta, Georgia

  Disclosure: Nothing to disclose